mRNA Vaccine Offers Complete Protection Against Pneumonic Plague in Animal Trials

Scientists in Tel Aviv and the Israel Institute for Biological Research (IIBR) have achieved a remarkable breakthrough in vaccine development. They’ve created a novel mRNA vaccine that combats the deadly bacterium *Yersinia pestis*, responsible for the plague.

100% Effective in Preclinical Studies

In promising preclinical trials, the vaccine demonstrated 100% effectiveness against pneumonic plague, a severe form of the disease that affects the lungs. This offers a glimmer of hope in the fight against this ancient and persistent threat.

Combating a Historical Threat in the Modern Age

*Yersinia pestis* is infamous for causing the Black Death, a devastating pandemic that swept across Europe, Asia, and Africa in the 14th century. While less prevalent today, the plague remains a concern, particularly with the rise of antibiotic-resistant strains. This new mRNA vaccine could provide a critical defense against future outbreaks.